Discovery identifies new RX target for age-rleated macular degeneration and Alzheimer's

March 7, 2016, Louisiana State University

For the first time, researchers at LSU Health New Orleans have shown that a protein critical to the body's ability to remove waste products from the brain and retina is diminished in age-related macular degeneration (AMD), after first making the discovery in an Alzheimer's disease (AD) brain. The research team, led by Walter Lukiw, PhD, Professor of Neurology, Neuroscience and Ophthalmology at LSU Health New Orleans Neuroscience Center, also discovered a key reason, identifying a new treatment target. The paper, microRNA-34a-mediated down-regulation of the microglial-enriched triggering receptor and phagocytosis-sensor TREM2 in age-related macular degeneration, was published March 7, 2016, online at in the journal, PLOS ONE.

During their normal day-to-day operation, the and retina produce relatively large quantities of waste products, which have to be cleared away so that they do not clog up the delicate parts of the thinking and visual system. Part of the waste disposal system consists of a very special waste-sensing transmembrane protein located in highly specialized cells called microglial cells found in the brain and retina. This waste-sensing protein in microglial cells is known to scientists as the "triggering receptor expressed in microglia," or TREM2 protein.

In this work, the researchers examined human AD-affected brain and AMD-affected retina, the retina of aging 5xFAD transgenic animals and microglial and other brain and retinal cells in culture.

"We have discovered that in age-related degenerative diseases of the brain, such as Alzheimer's disease, and the retina, such as age-related macular degeneration, there is a lowered and insufficient amount of TREM2 protein, and this may be in part responsible for the inability of the brain and retina to clear away their end-stage waste products," notes Dr. Lukiw, who is also the Bollinger Professor of Alzheimer's Disease at LSU Health New Orleans.

These waste products consist chiefly of amyloid—misfolded proteins, small various remnants of the innate immune system, small, very sticky toxic proteins and prominently, a 42-amino acid amyloid protein called Aβ42 peptide. Because they cannot be properly removed, the waste products accumulate in the brain and retina and contribute to the progressive appearance of insoluble lesions called senile plaques in the brain and drusen in the retina. These lesions ultimately contribute to episodes of age-related inflammatory degeneration.

"We have also discovered that an excessive amount of a small piece of ribonucleic acid (RNA) called microRNA-34a, or miRNA-34a, is in part responsible for insufficient TREM2 ," adds Dr. Lukiw. "These scientific findings further indicate that getting rid of the excessive miRNA-34a to restore normal TREM2 abundance may provide a highly effective therapeutic strategy for the treatment of both degenerative diseases of the brain, such as Alzheimer's disease, and progressive diseases of the , such as ."

Explore further: Potential new approaches to treating eye diseases

More information: Surjyadipta Bhattacharjee et al. microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration, PLOS ONE (2016). DOI: 10.1371/journal.pone.0150211

Related Stories

Potential new approaches to treating eye diseases

February 4, 2016
Potential new approaches to treating eye diseases such as age-related macular degeneration (AMD) are described in a new study, "IL-33 amplifies an innate immune response in the degenerating retina," in the February Journal ...

One step closer to defeating Alzheimer's disease

March 2, 2015
Tackling brain inflammation ameliorates Alzheimer's disease (AD), according to a study published in The Journal of Experimental Medicine.

A new biomarker of brain inflammation in early-stage Alzheimer's disease

March 3, 2016
Researchers at the Ludwig-Maximilians-University, the German Center for Neurodegenerative Diseases (DZNE), and the Institute for Stroke and Dementia Research (ISD) in Munich, Germany, have identified a brain inflammation ...

Research provides insight into the role of the western diet in Alzheimer's disease

March 7, 2016
Recent research has established associations between certain environmental factors, including eating a western diet and being sedentary, with an increased susceptibility to Alzheimer's disease. In fact, it is estimated that ...

Retina's cancer-like metabolism could lead to new treatments

December 5, 2014
Eye surgeons at the University of Adelaide have discovered that the retina in human eyes uses energy in a very similar way to cancer, which could lead to improved understanding of cancers as well as eye disease such as macular ...

Team discovers key to preventing blindness and stroke devastation

January 30, 2015
Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair of Retinal Degeneration Research, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered ...

Recommended for you

Sleep in your contacts, risk serious eye damage: CDC

August 16, 2018
(HealthDay)—A 59-year-old man was in the shower, wiping his eyes with a towel, when he heard a popping sound and felt pain shoot through his left eye.

Researchers reverse congenital blindness in mice

August 15, 2018
Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors. The findings advance efforts toward ...

Autoimmune response drives vision loss in glaucoma

August 10, 2018
A research team from Massachusetts Eye and Ear and the Massachusetts Institute of Technology has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive ...

Is too much screen time harming children's vision?

August 6, 2018
As children spend more time tethered to screens, there is increasing concern about potential harm to their visual development. Ophthalmologists—physicians who specialize in medical and surgical eye care—are seeing a marked ...

Researchers chart a course for AI-aided diagnosis of degenerative eye conditions

August 1, 2018
A team of researchers from Johns Hopkins is leading the way in understanding how the advent of electronic medical records with large image databases and advances in artificial intelligence with deep learning can offer medical ...

Derivative of turmeric eye drops could treat glaucoma

July 24, 2018
A derivative of turmeric could be used in eye drops to treat the early stages of glaucoma, finds a new study led by UCL and Imperial College London researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.